1. Japan Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
Sugi Holdings Co., Ltd.

Sugi Holdings Co., Ltd.

6.90
EUR
-0.15
(-2.13%)
0.42EPS
18.41P/E
2.82BMarket Cap
Jan 08Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
961.32
1,009.87
1,092.12
1,134.01
1,203.12
1,305.72
1,461.28
1,625.45
1,686.46
1,844.78
2,057.06
2,426.02
5,582.88
- -
Basic EPS, GAAP
33.75
33.86
38.45
39.35
43.2
47.96
56.03
56.95
52.28
52.52
60.73
70.98
248.56
- -
Free Cash Flow per Basic Share
26.51
64.4
7.87
13.23
41.7
12.87
67.31
33.61
-43.69
46.33
17.52
30.13
337.25
- -
Dividend per Share
5.16
7.33
6.67
8.33
8.33
11.71
12.49
13.33
13.33
13.57
13.33
14.17
34.97
- -
Book Value per Share
302.21
327.15
360.06
391.65
426.57
449.09
492.74
540.95
576.7
598.34
644.79
692.68
802.49
- -
Tangible Book Value per Share
296.63
318.78
352.04
383.11
418.76
441.01
483.19
526.59
558.87
575.9
616.18
548.71
660.09
- -
Basic Weighted Avg Shares
380
380
380
380
380
374
371
371
371
362
362
362
181
362
Sales/Revenue/Turnover
365,200
383,644
414,885
430,795
457,047
488,464
541,964
602,850
625,477
667,647
744,477
878,021
1,010,336
- -
Operating Margin (%)
5.51
5.44
5.57
5.3
5.42
5.29
5.49
5.65
5.14
4.74
4.92
4.85
4.81
- -
Depreciation Expense
4,994
4,952
5,267
5,599
6,455
7,389
8,412
9,940
11,268
12,362
14,179
17,871
20,110
- -
Net Income, GAAP
12,820
12,862
14,605
14,947
16,411
17,940
20,782
21,120
19,389
19,007
21,979
25,689
44,982
- -
Effective Tax Rate (%)
39.49
38.42
36.02
33.63
33.17
31.14
30.56
32.99
29.38
32.56
31.53
32.53
0.43
- -
Profit Margin (%)
3.51
3.35
3.52
3.47
3.59
3.67
3.83
3.5
3.1
2.85
2.95
2.93
4.45
- -
Working Capital
65,613
73,655
80,959
86,717
94,049
83,938
81,104
85,480
89,869
82,969
62,398
30,400
79,442
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
521
2,064
67,193
- -
Total Equity
114,808
124,281
136,783
148,781
162,046
166,562
182,748
200,629
213,888
216,537
233,361
250,704
290,473
- -
Return on Invested Capital (%)
10.8
10.41
10.97
10.39
10.42
10.53
11.52
11.54
10.74
9.77
10.83
10.53
13.97
- -
Return on Capital (%)
11.73
10.77
11.2
10.48
10.57
10.93
11.91
11.03
9.36
8.84
9.76
9.75
13.48
- -
Return on Common Equity (%)
11.72
10.76
11.19
10.47
10.56
10.92
11.9
11.02
9.35
8.83
9.77
10.61
16.62
- -

Capital Structure

JPY

•

in mil. unless spec.
May'25
Aug'25
May'27
ST Debt
10,816
10,771
- -
LT Borrowings
439
406
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
362
362
362
Market Capitalization
441,644
456,134
500,618

Working Capital

JPY

•

in mil. unless spec.
May'25
Aug'25
May'27
Total Current Assets
207,732
244,528
- -
Cash, Cash Equivalents & STI
48,732
78,181
- -
Accounts Receivable, Net
48,815
51,795
- -
Inventories
86,414
83,514
- -
Total Current Liabilities
150,890
181,649
- -
Payables & Accruals
- -
- -
- -
ST Debt
10,816
10,771
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.89%
7.78%
15.86%
Free Cash Flow
61.8%
7.2%
459.68%
Net Income, GAAP
13.64%
19.49%
75.1%
Sales/Revenue/Turnover
9.4%
11%
15.07%
Total Cash Common Dividend
- -
- -
23.44%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
200,959
212,850
- -
- -
878,021
2026
- -
- -
- -
- -
1,010,336
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
16.92
19.16
- -
- -
70.98
2026
- -
- -
- -
- -
248.56
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
14.17
2026
- -
- -
- -
- -
34.97
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Katsunori Sugiura
Full Time Employees
13,417
Sector
Retail trade
Industry
Drugstore chains
Address
62-1 Shine Yokonemachi Obu Japan 474-0011
IPO Date
Jun 19, 2000
Website
drug-sugi.co.jp
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
MedPlus Health Services Ltd. (NSE:MEDPLUS)
Raia Drogasil S.A. (B3:RADL3)
Business
Sugi Holdings Co., Ltd. is a Japan-based holding company that primarily engages in the operation of drugstores and dispensing pharmacies through its subsidiaries, offering prescription and generic drugs, over-the-counter medicines, health supplements, cosmetics, health and beauty goods, groceries, daily necessities, pet supplies, and health foods; it also provides self-care support services including meal delivery, cancer and health checkups, specific health guidance, disease prevention programs, home-visit nursing, shopping and mobility assistance, online medication instruction, and comprehensive community care in cooperation with regional medical institutions. The company operates over 2,100 stores primarily in the Kanto, Chubu, Kansai, and Hokuriku-Shinshu regions of Japan, with additional international activities in Asia through S Trading, including partnerships for product supply and expansion in countries such as Taiwan, Vietnam, Malaysia, Thailand, Hong Kong, Indonesia, and the Philippines. Founded in December 1976 and headquartered in Obu-City, Aichi, Japan, Sugi Holdings employs 11,820 people on a consolidated basis and reported net sales of 878.021 billion yen for the fiscal year ended February 2025. Recent developments include the August 2025 acquisition of a 34.8% stake in Seki Yakuhin Co., Ltd., a Saitama-based drugstore operator with over 300 stores, positioning it as an equity method affiliate with plans to increase ownership to 49% by September 2025 and to 51% within five years for full consolidation; strategic partnerships such as with PT Mustika Ratu Tbk in 2024 for halal cosmetics and drugs, and with AC Health in the Philippines in 2025 to distribute products across 800 outlets; and ongoing expansion of its Total Healthcare Strategy integrating digital tools like the SUGI Pharmacy App for personalized health management.